Axon Therapy
Electromagnetic Stimulator, Pain Relief. 510(k) K233364, from Neuralace Medical, Inc. (San Diego, CA). Product code QPL, class 2.
As of Nov 17, 2026, K233364 is an FDA 510(k) held by Neuralace Medical, Inc., substantially equivalent on Jan 10, 2024 after 100 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Jan 10, 2024
- Review time: 100 days
- Recalls: 0
- Cited as a predicate by: 1 device
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe Axon Therapy is intended to stimulate peripheral nerves for relief of chronic intractable pain, post-traumatic pain, post-surgical pain and/or for relief of chronic painful diabetic peripheral neuropathy in the lower extremities. The Axon Therapy is for use on patients 18 and older.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Axon TherapyK210021 · Neuralace Medical, Inc. · Jun 11, 2021
Cited as a Predicate
1 later 510(k) summary names this device as a predicate- BTL-199K250309 · BTL Industries, Inc. · Aug 7, 2025
Other QPL Clearances
The newest 510(k)s for the same product code; their median review was 185 days; see every QPL device- BTL-199K250309 · BTL Industries, Inc. · Aug 7, 2025
- Rapid2 Magnetic Stimulators (Magstim Rapid2, Magstim Super Rapid2, Magstim Super Rapid2…K250286 · The Magstim Company Limited · Jul 3, 2025
- StarFormer (M008-3T)K241785 · Fotona D.O.O. · Mar 27, 2025
- MagVenture Pain Therapy: MagPro R30, MagPro R30 with MagOption, MagPro X100, MagPro X100…K230014 · Tonica Elektronik A/S · Aug 25, 2023
- Axon TherapyK210021 · Neuralace Medical, Inc. · Jun 11, 2021
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Oct 2, 2023
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5890
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files